Cargando…
COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, March 1–June 30, 2020
Using a coronavirus disease 2019 (COVID-19)–associated hospitalization surveillance network, we found that 42.5% of hospitalized COVID-19 cases with available data from March 1–June 30, 2020, received ≥1 COVID-19 investigational treatment. Hydroxychloroquine, azithromycin, and remdesivir were used f...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686662/ https://www.ncbi.nlm.nih.gov/pubmed/33274249 http://dx.doi.org/10.1093/ofid/ofaa528 |
| _version_ | 1783613375315443712 |
|---|---|
| author | Acosta, Anna M Mathis, Adria L Budnitz, Daniel S Geller, Andrew I Chai, Shua J Alden, Nisha B Meek, James Anderson, Evan J Ryan, Patricia Kim, Sue Como-Sabetti, Kathryn Torres, Salina Dufort, Elizabeth Bennett, Nancy M Billing, Laurie M Sutton, Melissa Keipp Talbot, H George, Andrea Pham, Huong Hall, Aron J Fry, Alicia Garg, Shikha Kim, Lindsay |
| author_facet | Acosta, Anna M Mathis, Adria L Budnitz, Daniel S Geller, Andrew I Chai, Shua J Alden, Nisha B Meek, James Anderson, Evan J Ryan, Patricia Kim, Sue Como-Sabetti, Kathryn Torres, Salina Dufort, Elizabeth Bennett, Nancy M Billing, Laurie M Sutton, Melissa Keipp Talbot, H George, Andrea Pham, Huong Hall, Aron J Fry, Alicia Garg, Shikha Kim, Lindsay |
| author_sort | Acosta, Anna M |
| collection | PubMed |
| description | Using a coronavirus disease 2019 (COVID-19)–associated hospitalization surveillance network, we found that 42.5% of hospitalized COVID-19 cases with available data from March 1–June 30, 2020, received ≥1 COVID-19 investigational treatment. Hydroxychloroquine, azithromycin, and remdesivir were used frequently; however, hydroxychloroquine and azithromycin use declined over time, while use of remdesivir increased. |
| format | Online Article Text |
| id | pubmed-7686662 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76866622020-12-09 COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, March 1–June 30, 2020 Acosta, Anna M Mathis, Adria L Budnitz, Daniel S Geller, Andrew I Chai, Shua J Alden, Nisha B Meek, James Anderson, Evan J Ryan, Patricia Kim, Sue Como-Sabetti, Kathryn Torres, Salina Dufort, Elizabeth Bennett, Nancy M Billing, Laurie M Sutton, Melissa Keipp Talbot, H George, Andrea Pham, Huong Hall, Aron J Fry, Alicia Garg, Shikha Kim, Lindsay Open Forum Infect Dis Brief Report Using a coronavirus disease 2019 (COVID-19)–associated hospitalization surveillance network, we found that 42.5% of hospitalized COVID-19 cases with available data from March 1–June 30, 2020, received ≥1 COVID-19 investigational treatment. Hydroxychloroquine, azithromycin, and remdesivir were used frequently; however, hydroxychloroquine and azithromycin use declined over time, while use of remdesivir increased. Oxford University Press 2020-11-09 /pmc/articles/PMC7686662/ /pubmed/33274249 http://dx.doi.org/10.1093/ofid/ofaa528 Text en Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020. This work is written by (a) US Government employee(s) and is in the public domain in the US. http://www.nationalarchives.gov.uk/doc/open-government-licence/version/2/ This Open Access article contains public sector information licensed under the Open Government Licence v2.0 (http://www.nationalarchives.gov.uk/doc/open-government-licence/version/2/). |
| spellingShingle | Brief Report Acosta, Anna M Mathis, Adria L Budnitz, Daniel S Geller, Andrew I Chai, Shua J Alden, Nisha B Meek, James Anderson, Evan J Ryan, Patricia Kim, Sue Como-Sabetti, Kathryn Torres, Salina Dufort, Elizabeth Bennett, Nancy M Billing, Laurie M Sutton, Melissa Keipp Talbot, H George, Andrea Pham, Huong Hall, Aron J Fry, Alicia Garg, Shikha Kim, Lindsay COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, March 1–June 30, 2020 |
| title | COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, March 1–June 30, 2020 |
| title_full | COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, March 1–June 30, 2020 |
| title_fullStr | COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, March 1–June 30, 2020 |
| title_full_unstemmed | COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, March 1–June 30, 2020 |
| title_short | COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, March 1–June 30, 2020 |
| title_sort | covid-19 investigational treatments in use among hospitalized patients identified through the us coronavirus disease 2019–associated hospitalization surveillance network, march 1–june 30, 2020 |
| topic | Brief Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686662/ https://www.ncbi.nlm.nih.gov/pubmed/33274249 http://dx.doi.org/10.1093/ofid/ofaa528 |
| work_keys_str_mv | AT acostaannam covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT mathisadrial covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT budnitzdaniels covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT gellerandrewi covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT chaishuaj covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT aldennishab covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT meekjames covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT andersonevanj covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT ryanpatricia covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT kimsue covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT comosabettikathryn covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT torressalina covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT dufortelizabeth covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT bennettnancym covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT billinglauriem covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT suttonmelissa covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT keipptalboth covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT georgeandrea covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT phamhuong covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT hallaronj covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT fryalicia covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT gargshikha covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 AT kimlindsay covid19investigationaltreatmentsinuseamonghospitalizedpatientsidentifiedthroughtheuscoronavirusdisease2019associatedhospitalizationsurveillancenetworkmarch1june302020 |